Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
immunotherapy response 3. Immunotherapy resistance including with CRISPR screening 4. Mechanisms of response and resistance to MEK inhibition in HNSCCs 5. Clinical trials- novel neoadjuvant clinical trial
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
Therapy Postdoc Appointment Term: 1-year term with possible extension Appointment Start Date: As soon as possible (ASAP) Group or Departmental Website: https://med.stanford.edu/ross-lab (link is external
-
Demonstrated previous experience in human pluripotent stem cell culture Previous experience in genome edition of human pluripotent stem cells (CRISPR/Cas9 or equivalent) Demonstrated experience in organoid
-
: 1 year Appointment Start Date: Flexible Group or Departmental Website: http://www.sheltzerlab.org (link is external) How to Submit Application Materials: Email your application to Dr. Sheltzer Does
-
Stanford Cancer Center Pediatrics Postdoc Appointment Term: Two years Appointment Start Date: 1/1/2026 Group or Departmental Website: http://www.sheltzerlab.org (link is external) How to Submit Application
-
of the targets will avail of in vitro CRISPR/Cas9 screens and mechanistic studies to uncover novel potential vulnerabilities. Where to apply Website https://www.univr.it Requirements Additional Information
-
(https://www.unibas.ch/en/Research/Values-Ethics/Diversity-and-Inclusion.html ), we are committed to sustain and promote an inclusive culture, ensure equal opportunities and value diversity and respect in
-
research lab. The lab studies brain development and neurological disorders through molecular, cellular, developmental and computational analyses of normal and diseased neural tissues. We use CRISPR mouse
-
to work with animal models of disease. Familiarity with RNA biology, epigenetics, CRISPR-based approaches, or next-generation sequencing workflows. Experience contributing to peer-reviewed publications